Home » Blog » Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
1 View
SaveSavedRemoved 0
In a Part 2b core research, remibrutinib diminished rescue H1-antihistamine (H1-AH) use in power spontaneous urticaria (CSU) sufferers who additionally took concomitant background H1-AH at labelled dose. Right here we report the impact of remibrutinib monotherapy on rescue remedy use within the absence of background remedy in CSU sufferers from the Part 2b extension research.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
Added to wishlistRemoved from wishlist 0
$9.99
Added to wishlistRemoved from wishlist 0
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28